Gilead Sciences Is a Value Buy or a Trap?

Gilead Sciences (NASDAQ: GILD) is a biopharmaceutical company. The company had given stellar returns to the investors when the Hepatitis C drug sales were growing. Once the generics entered the market the sales dropped and […]